January 28, 2025

New Member: Welcome in our cluster to Menarini Biotech

New Member: Welcome in our cluster to Menarini Biotech
Go back

Menarini Biotech (MBH) is a leading CDMO specializing in Process Development and GMP manufacturing across various therapeutic areas. With a mission to be a reliable, agile, and innovative partner, MBH empowers its customers to bring life-saving biotherapeutics to patients through expertise in drug development.

From lab to production, cutting-edge technology accelerates processes, optimizes yields, and ensures precision at every stage. Guided by a vision of pioneering scientific breakthroughs, MBH applies innovative technologies to help find cures for difficult-to-treat diseases—transforming research insights into seamless clinical development.

If you would like to learn more, please visit their Website.
Looking forward to your active participation!

Our latest News

discover more
YUMAB and InSCREENeX are developing an innovative “Mammalian Display” screening platform to accelerate antibody development.

YUMAB and InSCREENeX are developing an innovative “Mammalian Display” screening platform to accelerate antibody development.

Braunschweig, January 29th, 2025 – YUMAB GmbH, a German biotechnology company specializing in contract research for therapeutic antibodies, announces its collaboration with InSCREENeX GmbH to establish a novel technology for antibody development. As part of the funded project “Mammalian Display,” the two Braunschweig-based companies are developing a platform that enables the screening of antibody libraries […]

read more
New Member: Welcome in our cluster to Menarini Biotech

New Member: Welcome in our cluster to Menarini Biotech

Menarini Biotech (MBH) is a leading CDMO specializing in Process Development and GMP manufacturing across various therapeutic areas. With a mission to be a reliable, agile, and innovative partner, MBH empowers its customers to bring life-saving biotherapeutics to patients through expertise in drug development. From lab to production, cutting-edge technology accelerates processes, optimizes yields, and […]

read more
New Member: Welcome in our cluster to GeneTechX

New Member: Welcome in our cluster to GeneTechX

At GeneTechX, they are developing a nutrigenomics platform that combines genetics and nutritional science to create personalized dietary solutions. Leveraging advanced gene-editing technologies like PrimeCRISPR, they investigate the intricate relationships between genes, diet, and health outcomes. By identifying genetic variations that affect nutrient metabolism, GeneTechX delivers tailored nutrition strategies to enhance health and prevent disease, […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp